RxNorm Concept ID 1723770

ixazomib 4 MG Oral Capsule

Semantic Concepts

RxNorm semantic concepts for the RxCUI 1723770 unique identifier include: ixazomib 4 MG Oral Capsule (7710325), ixazomib 4 MG (as ixazomib citrate 5.7 MG) Oral Capsule (7710324), ixazomib 4 MG Oral Capsule (7710318), Ixazomib (as ixazomib citrate) 4 mg oral capsule (12421311) and Product containing precisely ixazomib (as ixazomib citrate) 4 milligram/1 each conventional release oral capsule (clinical drug) (12421830).

RxNorm Atom ID: 7710325 - Prescribable Name

ixazomib 4 MG Oral Capsule

Field NameField ValueField Description
RXCUI1723770RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI7710325Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionixazomib 4 MG Oral CapsuleDescription of concept identifier
Term Type (TTY)PSNTerm type in source with name and description
Term Type NamePrescribable NameName of term type in source
Term Type DescriptionSynonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.Description of term type in source
CODE1723770"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_220906FThe source version
Source DateSeptember 06, 2022RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 7710324 - Synonym

ixazomib 4 MG (as ixazomib citrate 5.7 MG) Oral Capsule

Field NameField ValueField Description
RXCUI1723770RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI7710324Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionixazomib 4 MG (as ixazomib citrate 5.7 MG) Oral CapsuleDescription of concept identifier
Term Type (TTY)SYTerm type in source with name and description
Term Type NameSynonymName of term type in source
Term Type DescriptionSynonym of another TTY, given for clarity.Description of term type in source
CODE1723770"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_220906FThe source version
Source DateSeptember 06, 2022RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 7710318 - Semantic Clinical Drug

ixazomib 4 MG Oral Capsule

Field NameField ValueField Description
RXCUI1723770RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI7710318Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionixazomib 4 MG Oral CapsuleDescription of concept identifier
Term Type (TTY)SCDTerm type in source with name and description
Term Type NameSemantic Clinical DrugName of term type in source
Term Type DescriptionIngredient + Strength + Dose FormDescription of term type in source
CODE1723770"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_220906FThe source version
Source DateSeptember 06, 2022RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom 7710318 Attributes

PropertyValueExplanation
RXN AI{1723769} 1723734RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM{1723769} 1723735RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH4 MGAvailable drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM{1723769} AMSource of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUGUSDrug available for use in Humans
RXTERM FORMCapThe RxTerm dose form name for this drug

RxNorm Atom ID: 12421311 - Designated preferred name

Ixazomib (as ixazomib citrate) 4 mg oral capsule

Field NameField ValueField Description
RXCUI1723770RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI12421311Unique identifier for the atom (RxNorm Atom ID)
Concept DescriptionIxazomib (as ixazomib citrate) 4 mg oral capsuleDescription of concept identifier
Term Type (TTY)PTTerm type in source with name and description
Term Type NameDesignated preferred nameName of term type in source
Term Type DescriptionDescription of term type in source
CODE863996002"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVFContent view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceSNOMEDCT_USConcept source abbreviation
Source NameUS Edition of SNOMED CTThe official name for a source
Source Version2022_07_31The source version
Source DateSeptember 06, 2022RxNorm data last updated
Source License ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source license contact information
Source Content ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source content contact information
Source Short NameUS Edition of SNOMED CTThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 12421830 - Full form of descriptor

Product containing precisely ixazomib (as ixazomib citrate) 4 milligram/1 each conventional release oral capsule (clinical drug)

Field NameField ValueField Description
RXCUI1723770RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI12421830Unique identifier for the atom (RxNorm Atom ID)
Concept DescriptionProduct containing precisely ixazomib (as ixazomib citrate) 4 milligram/1 each conventional release oral capsule (clinical drug)Description of concept identifier
Term Type (TTY)FNTerm type in source with name and description
Term Type NameFull form of descriptorName of term type in source
Term Type DescriptionDescription of term type in source
CODE863996002"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVFContent view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceSNOMEDCT_USConcept source abbreviation
Source NameUS Edition of SNOMED CTThe official name for a source
Source Version2022_07_31The source version
Source DateSeptember 06, 2022RxNorm data last updated
Source License ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source license contact information
Source Content ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source content contact information
Source Short NameUS Edition of SNOMED CTThe short name of a source as used by the NLM Knowledge Source Server

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Information for Patients

Ixazomib

Ixazomib is used in combination with lenalidomide (Revlimid) and dexamethasone to treat multiple myeloma (cancer of the plasma cells in the bone marrow) that has worsened after treatment with other chemotherapy medications. Ixazomib is in a class of medications called proteasome inhibitors. It works by helping to kill cancer cells.
[Read More]
Cancer Chemotherapy

Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.

You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.

Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).

NIH: National Cancer Institute


[Read More]

* Please review the disclaimer below.